KLRA Institutional Ownership
Kailera Therapeutics, Inc.
1W: +1.9%
1M: +18.1%
3M: -22.2%
YTD: -49.5%
$13.13
+0.36 (+2.82%)
Weekly Expected Move ±13.3%
$9
$11
$13
$15
$16
Credit Risk of going bust: not rated Debt: 0.6% of company value Bonds: none of note held by US funds details ▾
Not rated: insufficient price history.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Institutional Ownership — KLRA
102
Institutional Holders
+0 vs prior quarter
0.0%
Ownership
+0.00pp
$3B
Total Invested
102
New Positions
0
Increased
0
Reduced
0
Closed
0.00
Put/Call Ratio
Ownership Trends
Top Institutional Holders (102 total)
| # | Holder | Shares | Value | Change | Change % | Holding Period | Filing |
|---|---|---|---|---|---|---|---|
| 1 | Bain Capital Investors LLC NEW | 26,255,581 | $345M | — | +0.0% | 1Q | SEC ↗ |
| 2 | Bain Capital Life Sciences Investors, NEW | 22,583,268 | $297M | — | +0.0% | 1Q | SEC ↗ |
| 3 | RTW INVESTMENTS, LP NEW | 10,776,820 | $141M | — | +0.0% | 1Q | SEC ↗ |
| 4 | CANADA PENSION PLAN INVESTMENT BOARD NEW | 7,304,688 | $96M | — | +0.0% | 1Q | SEC ↗ |
| 5 | Atlas Venture Life Science Advisors, L NEW | 5,171,282 | $68M | — | +0.0% | 1Q | SEC ↗ |
| 6 | FMR LLC NEW | 3,970,865 | $52M | — | +0.0% | 1Q | SEC ↗ |
| 7 | BlackRock, Inc. NEW | 3,928,604 | $52M | — | +0.0% | 1Q | SEC ↗ |
| 8 | PRICE T ROWE ASSOCIATES INC /MD NEW | 3,534,410 | $46M | — | +0.0% | 1Q | SEC ↗ |
| 9 | CITADEL ADVISORS LLC NEW | 3,240,787 | $43M | — | +0.0% | 1Q | SEC ↗ |
| 10 | ADAGE CAPITAL PARTNERS GP, L.L.C. NEW | 3,208,286 | $42M | — | +0.0% | 1Q | SEC ↗ |
| 11 | WELLINGTON MANAGEMENT GROUP LLP NEW | 2,919,110 | $38M | — | +0.0% | 1Q | SEC ↗ |
| 12 | Royalty Pharma Sub-Manager, LLC NEW | 2,455,357 | $32M | — | +0.0% | 1Q | SEC ↗ |
| 13 | Siren, L.L.C. NEW | 2,214,286 | $29M | — | +0.0% | 1Q | SEC ↗ |
| 14 | VANGUARD CAPITAL MANAGEMENT LLC NEW | 1,693,958 | $22M | — | +0.0% | 1Q | SEC ↗ |
| 15 | VANGUARD PORTFOLIO MANAGEMENT LLC NEW | 1,652,507 | $22M | — | +0.0% | 1Q | SEC ↗ |
| 16 | GEODE CAPITAL MANAGEMENT, LLC NEW | 1,133,115 | $15M | — | +0.0% | 1Q | SEC ↗ |
| 17 | Frazier Life Sciences Management, L.P. NEW | 1,100,000 | $14M | — | +0.0% | 1Q | SEC ↗ |
| 18 | FARALLON CAPITAL MANAGEMENT, L.L.C. NEW | 1,100,000 | $14M | — | +0.0% | 1Q | SEC ↗ |
| 19 | Trails Edge Capital Partners, LP NEW | 984,786 | $13M | — | +0.0% | 1Q | SEC ↗ |
| 20 | UBS Group AG NEW | 972,683 | $13M | — | +0.0% | 1Q | SEC ↗ |
| 21 | Jupiter Topco LLC NEW | 970,857 | $13M | — | +0.0% | 1Q | SEC ↗ |
| 22 | STATE STREET CORP NEW | 868,160 | $11M | — | +0.0% | 1Q | SEC ↗ |
| 23 | AMERIPRISE FINANCIAL INC NEW | 821,331 | $11M | — | +0.0% | 1Q | SEC ↗ |
| 24 | Deep Track Capital, LP NEW | 700,000 | $9M | — | +0.0% | 1Q | SEC ↗ |
| 25 | EVENTIDE ASSET MANAGEMENT, LLC NEW | 616,720 | $8M | — | +0.0% | 1Q | SEC ↗ |
| 26 | Vestal Point Capital, LP NEW | 575,000 | $8M | — | +0.0% | 1Q | SEC ↗ |
| 27 | Cormorant Asset Management, LP NEW | 550,000 | $7M | — | +0.0% | 1Q | SEC ↗ |
| 28 | Catalio Capital Management, LP NEW | 468,750 | $6M | — | +0.0% | 1Q | SEC ↗ |
| 29 | FEDERATED HERMES, INC. NEW | 434,069 | $6M | — | +0.0% | 1Q | SEC ↗ |
| 30 | GOLDMAN SACHS GROUP INC NEW | 421,034 | $6M | — | +0.0% | 1Q | SEC ↗ |
| 31 | FRANKLIN RESOURCES INC NEW | 400,023 | $5M | — | +0.0% | 1Q | SEC ↗ |
| 32 | CHARLES SCHWAB INVESTMENT MANAGEMENT I NEW | 362,910 | $5M | — | +0.0% | 1Q | SEC ↗ |
| 33 | Sixth Street Partners Management Compa NEW | 362,910 | $5M | — | +0.0% | 1Q | SEC ↗ |
| 34 | NORTHERN TRUST CORP NEW | 354,431 | $5M | — | +0.0% | 1Q | SEC ↗ |
| 35 | VANGUARD FIDUCIARY TRUST CO NEW | 290,128 | $4M | — | +0.0% | 1Q | SEC ↗ |
| 36 | SEVEN GRAND MANAGERS, LLC NEW | 175,000 | $2M | — | +0.0% | 1Q | SEC ↗ |
| 37 | Balyasny Asset Management L.P. NEW | 154,838 | $2M | — | +0.0% | 1Q | SEC ↗ |
| 38 | EXCHANGE TRADED CONCEPTS, LLC NEW | 152,501 | $2M | — | +0.0% | 1Q | SEC ↗ |
| 39 | MANUFACTURERS LIFE INSURANCE COMPANY, NEW | 149,817 | $2M | — | +0.0% | 1Q | SEC ↗ |
| 40 | TD Asset Management Inc NEW | 147,698 | $2M | — | +0.0% | 1Q | SEC ↗ |
| 41 | Nantahala Capital Management, LLC NEW | 140,000 | $2M | — | +0.0% | 1Q | SEC ↗ |
| 42 | Aberdeen Group plc NEW | 140,000 | $2M | — | +0.0% | 1Q | SEC ↗ |
| 43 | a16z Capital Management, L.L.C. NEW | 140,000 | $2M | — | +0.0% | 1Q | SEC ↗ |
| 44 | Bank of New York Mellon Corp NEW | 138,399 | $2M | — | +0.0% | 1Q | SEC ↗ |
| 45 | ALPS ADVISORS INC NEW | 131,000 | $2M | — | +0.0% | 1Q | SEC ↗ |
| 46 | Nuveen, LLC NEW | 88,796 | $1M | — | +0.0% | 1Q | SEC ↗ |
| 47 | Avidity Partners Management LP NEW | 80,000 | $1M | — | +0.0% | 1Q | SEC ↗ |
| 48 | Ghisallo Capital Management LLC NEW | 75,000 | $985K | — | +0.0% | 1Q | SEC ↗ |
| 49 | Rock Springs Capital Management LP NEW | 65,000 | $853K | — | +0.0% | 1Q | SEC ↗ |
| 50 | ALLIANCEBERNSTEIN L.P. NEW | 61,090 | $802K | — | +0.0% | 1Q | SEC ↗ |
Recent Activity
New Positions (20)
| Holder | Shares | Value |
|---|---|---|
| Bain Capital Investors LLC | 26,255,581 | $345M |
| Bain Capital Life Sciences Investor | 22,583,268 | $297M |
| RTW INVESTMENTS, LP | 10,776,820 | $141M |
| CANADA PENSION PLAN INVESTMENT BOAR | 7,304,688 | $96M |
| Atlas Venture Life Science Advisors | 5,171,282 | $68M |
| FMR LLC | 3,970,865 | $52M |
| BlackRock, Inc. | 3,928,604 | $52M |
| PRICE T ROWE ASSOCIATES INC /MD | 3,534,410 | $46M |
| CITADEL ADVISORS LLC | 3,240,787 | $43M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,208,286 | $42M |
| WELLINGTON MANAGEMENT GROUP LLP | 2,919,110 | $38M |
| Royalty Pharma Sub-Manager, LLC | 2,455,357 | $32M |
| Siren, L.L.C. | 2,214,286 | $29M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,693,958 | $22M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,652,507 | $22M |
| GEODE CAPITAL MANAGEMENT, LLC | 1,133,115 | $15M |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 1,100,000 | $14M |
| Frazier Life Sciences Management, L | 1,100,000 | $14M |
| Trails Edge Capital Partners, LP | 984,786 | $13M |
| UBS Group AG | 972,683 | $13M |
Sold Out (0)
No sold-out positions this quarter.
Biggest Increases (0)
None.
Biggest Decreases (0)
None.